Annual Total Long Term Liabilities
$531.00 M
+$353.58 M+199.28%
December 1, 2024
Summary
- As of February 25, 2025, GMAB annual total long term liabilities is $531.00 million, with the most recent change of +$353.58 million (+199.28%) on December 1, 2024.
- During the last 3 years, GMAB annual total long term liabilities has risen by +$399.62 million (+304.17%).
- GMAB annual total long term liabilities is now at all-time high.
Performance
GMAB Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$531.00 M
+$58.74 M+12.44%
December 1, 2024
Summary
- As of February 25, 2025, GMAB quarterly total long term liabilities is $531.00 million, with the most recent change of +$58.74 million (+12.44%) on December 1, 2024.
- Over the past year, GMAB quarterly long term liabilities has increased by +$58.74 million (+12.44%).
- GMAB quarterly long term liabilities is now at all-time high.
Performance
GMAB Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
GMAB Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +199.3% | +12.4% |
3 y3 years | +304.2% | +12.4% |
5 y5 years | +2141.7% | +12.4% |
GMAB Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +304.2% | at high | +313.4% |
5 y | 5-year | at high | +2141.7% | at high | +2141.7% |
alltime | all time | at high | -100.0% | at high | -100.0% |
Genmab A/S Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $531.00 M(+199.3%) | $531.00 M(+12.4%) |
Sep 2024 | - | $472.26 M(+0.1%) |
Jun 2024 | - | $471.71 M(+129.0%) |
Mar 2024 | - | $205.99 M(+16.1%) |
Dec 2023 | $177.42 M(+21.6%) | $177.42 M(+2.3%) |
Sep 2023 | - | $173.35 M(-3.4%) |
Jun 2023 | - | $179.49 M(-1.8%) |
Mar 2023 | - | $182.83 M(+25.3%) |
Dec 2022 | $145.94 M(+11.1%) | $145.94 M(+6.1%) |
Sep 2022 | - | $137.59 M(-6.7%) |
Jun 2022 | - | $147.42 M(+14.8%) |
Mar 2022 | - | $128.45 M(-2.2%) |
Dec 2021 | $131.38 M(+3.4%) | $131.38 M(-3.2%) |
Sep 2021 | - | $135.73 M(-3.6%) |
Jun 2021 | - | $140.83 M(+8.7%) |
Mar 2021 | - | $129.56 M(+1.9%) |
Dec 2020 | $127.10 M(+436.6%) | $127.10 M(+2.4%) |
Sep 2020 | - | $124.09 M(+2.4%) |
Jun 2020 | - | $121.14 M(+397.1%) |
Mar 2020 | - | $24.37 M(+2.9%) |
Dec 2019 | $23.69 M(+5054.0%) | $23.69 M(+0.5%) |
Sep 2019 | - | $23.58 M(-6.9%) |
Jun 2019 | - | $25.33 M(-1.9%) |
Mar 2019 | - | $25.83 M(+5519.2%) |
Dec 2018 | $459.60 K(-21.4%) | $459.60 K(-13.9%) |
Sep 2018 | - | $534.00 K(-3.7%) |
Jun 2018 | - | $554.40 K(-9.8%) |
Mar 2018 | - | $614.50 K(+5.1%) |
Dec 2017 | $584.80 K(>+9900.0%) | $584.80 K(+138.5%) |
Sep 2017 | - | $245.20 K(>+9900.0%) |
Jun 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $0.00 | $0.00(0.0%) |
Sep 2016 | - | $0.00(-100.0%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2016 | - | $214.30 K(-1.7%) |
Mar 2016 | - | $217.90 K(+3.8%) |
Dec 2015 | $209.90 K(-99.3%) | $209.90 K(-2.9%) |
Sep 2015 | - | $216.20 K(+0.4%) |
Jun 2015 | - | $215.40 K(-0.4%) |
Mar 2015 | - | $216.30 K(-99.3%) |
Dec 2014 | $29.03 M(-4.7%) | $29.03 M(-4.3%) |
Sep 2014 | - | $30.33 M(-3.6%) |
Jun 2014 | - | $31.46 M(+3.1%) |
Mar 2014 | - | $30.53 M(+0.3%) |
Dec 2013 | $30.45 M(+36.3%) | $30.45 M(+37.0%) |
Sep 2013 | - | $22.23 M(+3.2%) |
Jun 2013 | - | $21.55 M(+1.8%) |
Mar 2013 | - | $21.17 M(-5.3%) |
Dec 2012 | $22.34 M(+26.6%) | $22.34 M(+67.8%) |
Sep 2012 | - | $13.31 M(+5.7%) |
Jun 2012 | - | $12.59 M(-27.4%) |
Mar 2012 | - | $17.33 M(-1.8%) |
Dec 2011 | $17.65 M(+28.6%) | $17.65 M(+51.1%) |
Sep 2011 | - | $11.68 M(-7.7%) |
Jun 2011 | - | $12.65 M(-3.8%) |
Mar 2011 | - | $13.15 M(-4.2%) |
Dec 2010 | $13.72 M(+174.6%) | $13.72 M(+100.2%) |
Sep 2010 | - | $6.85 M(-2.4%) |
Jun 2010 | - | $7.03 M(+45.7%) |
Mar 2010 | - | $4.82 M(-3.5%) |
Dec 2009 | $5.00 M(+94.8%) | $5.00 M |
Dec 2008 | $2.57 M(+60.3%) | - |
Dec 2007 | $1.60 M(-19.6%) | - |
Dec 2006 | $1.99 M(-13.4%) | - |
Dec 2005 | $2.30 M(-39.8%) | - |
Dec 2004 | $3.82 M(+21.5%) | - |
Dec 2003 | $3.14 M(-5.6%) | - |
Dec 2002 | $3.33 M | - |
FAQ
- What is Genmab A/S annual total long term liabilities?
- What is the all time high annual total long term liabilities for Genmab A/S?
- What is Genmab A/S annual total long term liabilities year-on-year change?
- What is Genmab A/S quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Genmab A/S?
- What is Genmab A/S quarterly long term liabilities year-on-year change?
What is Genmab A/S annual total long term liabilities?
The current annual total long term liabilities of GMAB is $531.00 M
What is the all time high annual total long term liabilities for Genmab A/S?
Genmab A/S all-time high annual total long term liabilities is $531.00 M
What is Genmab A/S annual total long term liabilities year-on-year change?
Over the past year, GMAB annual total long term liabilities has changed by +$353.58 M (+199.28%)
What is Genmab A/S quarterly total long term liabilities?
The current quarterly long term liabilities of GMAB is $531.00 M
What is the all time high quarterly long term liabilities for Genmab A/S?
Genmab A/S all-time high quarterly total long term liabilities is $531.00 M
What is Genmab A/S quarterly long term liabilities year-on-year change?
Over the past year, GMAB quarterly total long term liabilities has changed by +$58.74 M (+12.44%)